Clinical Trials Browser

Interventional × Myelodysplastic Syndromes × Infusions, Intravenous × Clear all

NCT03238248 2024-11-04

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

Phase 2 Completed

71 enrolled 13 charts

Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT05448599 2023-03-15

A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Phase 1/2 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute